DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF. PREEMPT 1 Chronic Migraine Study Group..
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Cephalalgia 2010;
30: 793-803.
We do not assume any responsibility for the contents of the web pages of other providers.